- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/16 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
Patent holdings for IPC class C07D 295/16
Total number of patents in this class: 133
10-year publication summary
|
10
|
8
|
5
|
2
|
4
|
3
|
8
|
8
|
7
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Amgen Inc. | 4290 |
7 |
| Bristol-myers Squibb Company | 4795 |
5 |
| Araxes Pharma LLC | 92 |
5 |
| EA Pharma Co., Ltd. | 91 |
4 |
| Nippon Soda Co., Ltd. | 888 |
4 |
| Mitsui Chemicals, Inc. | 3232 |
3 |
| Council of Scientific & Industrial Research | 1433 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 865 |
3 |
| Toyama Chemical Co., Ltd. | 98 |
3 |
| Celltaxis, LLC | 28 |
3 |
| Nanjing Immunophage BioTech Co., Ltd. | 21 |
3 |
| The Regents of the University of California | 20355 |
2 |
| Sumitomo Chemical Company, Limited | 9039 |
2 |
| The Johns Hopkins University | 5772 |
2 |
| Ajinomoto Co., Inc. | 2302 |
2 |
| The Board of Trustees of the University of Illinois | 2731 |
2 |
| Northwestern University | 3483 |
2 |
| Astellas Pharma Inc. | 1050 |
2 |
| Hawaii Biotech, Inc. | 21 |
2 |
| Icahn School of Medicine at Mount Sinai | 987 |
2 |
| Other owners | 72 |